Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 2,010 shares at $19.16 ($5K) on 2021-02-25, disclosed to the SEC on 2021-02-25.
Scheduled sale ($5k) by VP, Qual, Reg, & Clin Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,744 | $0 | 0.0% |
| 2 | $19.16 | 266 | $5K | 100.0% |
| Total | $2.54 avg | 2,010 | $5K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-22 | $6K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $676K | — | Filing → |